Company page

Editas Medicine, Inc.

Editas Medicine, Inc. is a public biotechnology company based in the United States, focused on developing transformative gene-editing therapies. The company is traded under the ticker symbol EDIT and has a market capitalization of approximately $415.9 million. Editas aims to leverage its proprietary technology to address genetic diseases and improve patient outcomes.